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Chikungunya-
related Fatality 
Rates, Mauritius, 
India, and 
Reunion Island 
To the Editor: During the epi-
demic of chikungunya virus infection 
that occurred on Reunion Island in 
2005–06, we reported an overmor-
tality corresponding to the epidemic 
peak, which was estimated by compar-
ing observed and expected deaths (1). 
The excess was similar to the number 
of deaths related to chikungunya in-
fection reported by death certifi cates 
(2). The case-fatality rate (CFR) on 
Reunion Island was estimated to be 
1/1,000 population.
According to Beesoon et al. (3), 
the fatality rate attributable to chikun-
gunya infection was much higher on 
Mauritius: 743 deaths in excess of ex-
pected deaths led to a CFR of ≈4.5%, 
with 15,760 confi rmed or suspected 
cases for 2005 and 2006 as reported in 
this letter. A similar CFR of 4.9% can 
be calculated for the city of Ahmeda-
bad, India, during the 2006 chikungu-
nya epidemic (4).
This 45- to 49-fold difference 
could be explained by a greater sever-
ity of chikungunya infection in Mau-
ritius or Ahmedabad that could be due 
to a mutating strain, differences in 
the preexisting conditions of patients, 
differences in the management of pa-
tients, or by coincident deaths in ex-
cess from other causes.
However, the most probable ex-
planation can be attributed to the sur-
veillance systems of chikungunya cas-
es. On Reunion Island, surveillance 
was highly sensitive and relied either 
on active case fi nding or on estimates 
of suspected cases. Results have been 
assessed by iterative external stud-
ies and serosurveys, and the CFR we 
found is likely consistent.
If we apply this rate to Mauritius, 
≈60% of the population would have 
contracted chikungunya infection dur-
ing this epidemic. If so, the risk of 
epidemic resurgence could be much 
lower than previously expected. This 
point raises the need to conduct sero-
prevalence studies in those territories, 
the only way to evaluate the herd im-
munity level of the population.
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Aquaculture and 
Florfenicol 
Resistance in 
Salmonella enterica 
Typhimurium DT104
To the Editor: In June 2006, the 
World Health Organization (WHO), 
the Food and Agriculture Organiza-
tion of the United Nations (FAO), 
and the World Organisation for Ani-
mal Health (OIE) convened an Expert 
Consultation to consider the risks to 
human health represented by the use 
of antimicrobial drugs in aquaculture. 
This would, therefore, appear to be 
an opportune time to reexamine some 
of the arguments that have been pre-
sented with respect to the assessment 
of these risks.
In their contributions to the de-
bate regarding the risks associated 
with the use of antimicrobial agents in 
aquaculture, Angulo (1), Angulo and 
Griffi n (2), Ribot et al. (3), and, more 
recently, Cabello (4) have argued that 
the available molecular evidence sug-
gests that the fl o gene that encodes 
chloramphenicol and fl orfenicol resis-
tance in Salmonella enterica serovar 
Typhimurium DT104 (DT104) origi-
nally emerged in Japanese aquaculture 
and may have transferred horizontally 
from this host to DT104. This argu-
ment also appears in the report of the 
WHO/FAO/OIE consultation (ftp://
ftp.fao.org/ag/agn/food/aquaculture_
rep_13_16june2006.pdf). These au-
thors (1–4) have based their argument 
on the assertions that fl orfenicol was 
fi rst used in Japan and that fl o gene–
mediated resistance to this agent was 
fi rst identifi ed in bacteria isolated from 
Japanese fi sh farms.
In attempting to identify the date 
of the emergence of fl orfenicol resis-
tance in Japanese aquaculture, Angu-
lo and Griffi n (2) state that fl orfenicol 
had been used in this country since 
the early 1980s. However, Scher-
ing Plough, the manufacturer of fl o-
rfenicol, reports fi rst marketing this 
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agent for aquacultural use in Japan 
in 1990 (D. Schofi eld, pers. comm.), 
and this date for the introduction of 
fl orfenicol is also provided by Kim et 
al. (5). It should, however, be noted 
that the fl o gene encodes resistance to 
both fl orfenicol and chloramphenicol 
and, therefore, fl o-containing bacte-
ria could be selected for by the use 
of either agent. As a consequence, 
arguments about the chronology of 
the fi rst use of fl orfenicol may have 
limited relevance.
Florfenicol resistance in Japa-
nese aquaculture (5) was fi rst report-
ed in strains of Pasteurella piscicida 
(now renamed Vibrio damsela). The 
sequence of the gene that encoded 
fl orfenicol resistance in these strains 
(6) was demonstrated to have a 97% 
nucleotide sequence similarity to that 
found in strains of DT104 resistant to 
ampicillin, chloramphenicol, strepto-
mycin, sulfonamide, and tetracycline 
(ACSSuT DT104) (7). The available 
data (5,8) allow a reasonably accurate 
estimate of the date when these fl o-
rfenicol-resistant strains fi rst emerged 
in Japanese aquaculture. The strains 
of fl orfenicol-resistant P. piscicida 
were fi rst isolated in Japan in 1992 
(5). However, a previous study (8) had 
demonstrated 100% susceptibility to 
fl orfenicol of P. piscicida strains isolat-
ed from 1989 through 1991. Because 
this study examined 175 P. piscicida 
strains isolated from fi sh farms dis-
tributed over a wide geographic area 
in Japan, the data it generated provide 
strong support for the conclusions that 
fl o-mediated fl orfenicol resistance in 
P. piscicida fi rst emerged in Japanese 
aquaculture in 1992 (5). However, the 
presence of the fl oR gene has been 
demonstrated in a strain of ACSSuT 
DT104 isolated in the United States 
in 1985 (3). Thus, the fl oR gene was 
present in DT104 strains isolated in 
the United States at least 7 years be-
fore the fi rst bacteria containing this 
gene (6) were isolated from an aqua-
culture setting in Japan (5).
There are, however, data indi-
cating that the fl o gene was present 
in terrestrial bacteria associated with 
humans long before it was detected 
in multidrug -resistant DT104. A gene 
with a 95%–97% nucleotide identity 
with the fl o gene of DT104 was detect-
ed in the Inc C plasmid R55 (9). This 
plasmid was originally identifi ed in 
a chloramphenicol-resistant strain of 
Klebsiella pneumoniae isolated from 
a person in Paris in 1969 (10).
The earliest report of the isola-
tion of a bacterium whose fl orfenicol 
resistance was encoded by a fl o gene 
(6) and the earliest accession date for a 
fl o gene sequence in GenBank (www.
ncbi.nlm.nih.gov/Genbank) both re-
lated to P. damsela isolated from 
Japanese aquaculture. Publication 
and accession dates do not, however, 
constitute evidence of the date of the 
fi rst isolation of a bacterium contain-
ing this gene. Analysis of the available 
chronological and molecular data pre-
sented here indicates that a variant of 
the fl oR gene in DT104 (9) was pres-
ent in a terrestrial bacterium isolated 
in 1969 (10), 23 years before the fi rst 
isolation, in 1992, of a bacterium asso-
ciated with aquaculture that contained 
this gene (5). It further demonstrates 
that this gene was present in strains of 
DT104 isolated in 1985. Thus, these 
data provide no support for the argu-
ments (1–4) that implicate aquacultur-
al use of fl orfenicol or the subsequent 
occurrence of fl orfenicol-resistant P. 
damsela in the emergence of the fl o 
gene in DT104.
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